Ping An Biomedical Co., Ltd. (PASW) Form 6-K — Oct 30, 2026
Ping An Biomedical shareholders ratified a 40-for-1 share consolidation effective October 23, 2026, at an October 29 Extraordinary General Meeting, with all seven proposals passing by overwhelming margins (over 1.29 billion votes for, roughly 30,000 against each). The company also secured pre-approval for contingent further consolidations of 10-1, 20-1, 50-1, or 80-1 that would trigger automatically if the Class A shares close below $1.00 for 20 consecutive days (or 5 days if below $0.10). Alongside the split, shareholders approved increasing authorized share capital from $312,500 to $12.5 million and adopting amended memoranda and articles of association.
Key figures
- Shares Outstanding
- 112,867,000 Class A and 12,250,000 Class B ordinary shares (pre-consolidation, as of record date)
- Record date
- 2026-09-29
- Reverse split ratio
- 40:1 (effective 2026-10-23); contingent 10:1, 20:1, 50:1, or 80:1 further consolidations
- Class b vote multiplier
- 100
- Post split class a authorized
- 122,500,000
- Authorized share capital after increase
- US$12,500,000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.